Srinakharinwirot University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Bangkok Thailand (1949)

Organization Overview

First Clinical Trial
2009
NCT01052597
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Department of Medicine, Faculty of Medicine, Srinakharinwirot University | Faculty of Medicine, Srinakharinwirot University | Faculty of Pharmacy, Srinakharinwirot University | Srinakarinwirot University | Srinakharinwirot University | Wannisa Suphachearabhan

Active Ingredients

Drugs in Phase 4 Trials (8)

curcumin (2 trials)

dexamethasone (1 trial)

lamivudine (epivir) (1 trial)

loteprednol (lotemax) (1 trial)

nevirapine (viramune) (1 trial)

stavudine (zerit) (1 trial)

urea (1 trial)

zidovudine (retrovir) (1 trial)

Drugs in Phase 3 Trials (1)

zingiber (1 trial)

Drugs in Phase 2 Trials (1)

Tetrachlorodecaoxide (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Abnormalities (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Glucose Intolerance (Phase 4)

Hepatitis (Phase 4)

Hyperglycemia (Phase 4)

Insulin Resistance (Phase 4)

Osteoarthritis (Phase 3)

Prediabetic State (Phase 4)

Pterygium (Phase 4)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 11